40 Participants NeededMy employer runs this trial

Acute Intermittent Hypoxia for Spinal Cord Injury

(DOSA-SCI Trial)

MS
Overseen ByMilap Sandhu, PhD, PT
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Milap Sandhu
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study aims to evaluate how different doses of acute intermittent hypoxia (AIH) affect lower-limb strength, reaction time, and responsiveness in individuals with spinal cord injury (SCI). The objective is to identify the dose that most effectively improves motor output while also examining parameters that may account for variability in response.

Who Is on the Research Team?

MS

Milap Sandhu, PT, PhD

Principal Investigator

Shirley Ryan AbilityLab

Are You a Good Fit for This Trial?

This trial is for adults with spinal cord injury and paralysis. Participants should be able to safely undergo breathing treatments and follow study instructions. People with medical conditions that could make participation unsafe or interfere with results cannot join.

Inclusion Criteria

I have had a spinal cord injury for more than 6 months.
Motor incomplete SCI classified as AIS C or D
I can push my foot downward on my own in at least one leg.

Exclusion Criteria

Concurrent medical illness
My blood pressure is not well controlled.
I have lung-related health problems.
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • Acute Intermittent Hypoxia (AIH)

Trial Overview

The study compares different doses of a special breathing treatment called acute intermittent hypoxia (AIH) to see which dose best improves leg strength and reaction time in people with spinal cord injuries. A sham (placebo) group is also included.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Sham + AIH 15 + AIH 23Experimental Treatment1 Intervention
Group II: AIH 23 + AIH 15 + ShamExperimental Treatment1 Intervention
Group III: AIH 15 + Sham + AIH 23Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Milap Sandhu

Lead Sponsor

Trials
1
Recruited
110+

Shirley Ryan AbilityLab

Collaborator

Trials
212
Recruited
17,900+